kanjinti Archives - Medical Channel Asia

Tag: kanjinti

Access1 Access2 Cancer Medication & Drugs Women's Health

October 3, 2021

Treatment of HER2+ Breast Cancer: Kanjinti, a biosimilar to trastuzumab

Looking for health news and information? Stay updated with MCA’s health articles!

Health Conditions that you’re most interested in

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

About Us

Advertise

Contact Us

My Account

Privacy Policy

FOLLOW MCA

ACCREDITATIONS

Looking for health news and information? Stay updated with MCA’s health articles!

Health Conditions that you’re most interested in

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

About Us

Advertise

FOLLOW MCA

ACCREDITATIONS

Copyright © Medical Channel Asia 2022. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

Treatment of HER2+ Breast Cancer: Kanjinti, a biosimilar to trastuzumab

Recent Posts

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

About Us

Advertise

Contact Us

My Account

Privacy Policy

FOLLOW MCA

ACCREDITATIONS

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

FOLLOW MCA

ACCREDITATIONS

Copyright © Medical Channel Asia 2022. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

Register to access the Medical Channel Asia HCP Portal. Get the latest healthcare news, expert insights, and exclusive interviews.

For Healthcare Professionals Only. Access is free.

Register to access the Medical Channel Asia HCP Portal. Get the latest healthcare news, expert insights, and exclusive interviews.

For Healthcare Professionals Only. Access is free.

Treatment of HER2+ Breast Cancer: Kanjinti, a biosimilar to trastuzumab

Recent Posts

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

About Us

Advertise

Contact Us

My Account

Privacy Policy

FOLLOW MCA

ACCREDITATIONS

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

FOLLOW MCA

ACCREDITATIONS

Copyright © Medical Channel Asia 2022. All rights reserved. The contents on Medical Channel Asia are for general educational purposes only. It is not intended to be a substitute for professional medical advice, treatment, or diagnosis. See additional information.

Register to access the Medical Channel Asia HCP Portal. Get the latest healthcare news, expert insights, and exclusive interviews. For Healthcare Professionals Only. Access is free.

Have a health question?

Copyright © Medical Channel Asia 2022. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

Register to access the Medical Channel Asia HCP Portal. Get the latest healthcare news, expert insights, and exclusive interviews.

For Healthcare Professionals Only. Access is free.